Inventor · disambiguated record
Estefania Traver Lopez
Also filed as: TRAVER LOPEZ ESTEFANIA · TRAVER LÓPEZ ESTEFANIA
0 granted patents·3 pending applications·0 citations·filing 2019–2023
Files withMINORYX THERAPEUTICS S L3
Top patents by PatentIndex Score
3 records- 0168US2024091210A1Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its saltsMINORYX THERAPEUTICS S L·Filed 2023·Application pending·0 cites
- 0250US2021228558A1Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its saltsMINORYX THERAPEUTICS S L·Filed 2019·Application pending·0 cites
- 0348US2023172921A1Leriglitazone for treating lung inflammation and interstitial lung diseaseMINORYX THERAPEUTICS S L·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Estefania Traver Lopez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →